Creating a mobile app to help adults with PTSD
Official title: Development and Evaluation of a Novel Digital Therapeutic for Adults with Post-Traumatic Stress Disorder
Funded at Oui Therapeutics, INC · NIH-11105937 · Data updated 2026-11-12
This study is testing a new mobile app called OTX-601 that aims to help adults with post-traumatic stress disorder (PTSD) by making treatment easier and more personal, so you can manage your symptoms right from your phone.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oui Therapeutics, INC NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | June 5, 2024 |
| Project end | May 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $417,356 |
| NIH project number | 5R44MH136888-02 |
| Project ID | NIH-11105937 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who are experiencing symptoms of PTSD.
✕Less likely to help
Patients who do not have PTSD or those who are under 21 years old may not benefit from this research.
What this research studies
This research focuses on developing a mobile application called OTX-601 designed to assist adults suffering from post-traumatic stress disorder (PTSD). The project aims to address barriers to traditional treatments by providing a digital therapeutic that is accessible and user-friendly. The research will involve creating the app, assessing its usability, and conducting trials to evaluate its effectiveness in alleviating PTSD symptoms. By leveraging technology, the goal is to enhance treatment accessibility and personalization for individuals affected by PTSD.
Why it matters
Potential benefit: If successful, this research could provide a convenient and effective treatment option for adults with PTSD, improving their quality of life.
How similar studies have gone: Previous research has shown promise in using digital therapeutics for mental health conditions, indicating potential success for this novel approach.
Where this research is happening
-
Oui Therapeutics, INC
New Haven, United States Active
Researchers
- Principal investigator: Simon, Patricia — Oui Therapeutics, INC
- Study coordinator: Simon, Patricia
Related research
Other NIH-funded projects on the same topics.
-
Pimavanserin for Sleep Problems in Veterans with PTSD
This grant supports Dr. Melissa Jones to study a new medicine, pimavanserin, to help veterans with PTSD sleep better.
-
A new sleep-help approach for Veterans with PTSD
A new ACT-based insomnia treatment tailored for Veterans with PTSD aims to improve sleep and quality of life.
-
Novel digital therapeutic app to help adults with PTSD
A new mobile app-based treatment for adults living with PTSD aims to provide an accessible, personalized therapy option.
-
Light touches the brain: targeted ultrasound to help frontline workers with PTSD
A single, MRI-guided low-intensity focused ultrasound session is being tested to gently modulate a brain circuit involved in PTSD for frontline healthcare workers who have PTSD symptoms.
-
Methylphenidate for PTSD with cognitive symptoms in veterans
A controlled trial tests whether methylphenidate helps veterans with PTSD and cognitive problems feel and think more clearly.
-
Preventing awareness during paralysis in emergency ventilated patients and reducing PTSD
This project will change emergency department medication defaults to cut back on a paralytic drug and see if that lowers the chance that adults put on ventilators wake up while paralyzed and later develop PTSD.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.